Breaking News: Scilex Holding Company Teams Up with CH Trading Group to Take Over the World (Well, Maybe Just Some Territories)!

Welcome to the CH Trading Group Blog! Breaking News: Scilex Holding Company Enters Master Distributor Agreement Hey there fellow traders! We have some exciting news to share with you today. It has just been announced that Scilex Holding Company has entered into a Master Distributor Agreement with CH Trading Group LLC, covering designated territories including…

Read More

Get Ready to Unlock Your Potential: OpenLocker Sponsors and Joins the Exciting NIL Summit in Atlanta, GA June 3-5!

Welcome to the OpenLocker Blog! OpenLocker Announces Sponsorship of NIL Summit in Atlanta Hey there, fellow sports enthusiasts! We are thrilled to announce that OpenLocker, Inc., a subsidiary of OpenLocker Holdings Inc., will be sponsoring and participating with a significant presence at the upcoming NIL Summit in Atlanta, GA. The event is scheduled to take…

Read More

Attention Canopy Growth Investors: Important Class Action Lawsuit and Deadline Notification from Kaplan Fox Kilsheimer LLP

CANOPY GROWTH INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Canopy Growth Investors of a Class Action Lawsuit and Upcoming Deadline New York, May 31, 2023 (GLOBE NEWSWIRE) – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of Canopy Growth Corporation (“Canopy Growth” or the “Company”)…

Read More

Unleashing Potential: Granite Creek Capital Partners Invests in Pinstripes Inc.

Granite Creek Capital Partners Announces Investment in Pinstripes, Inc. CHICAGO, May 31, 2023 (GLOBE NEWSWIRE) Granite Creek Capital Partners, L.L.C., a private investment firm based in Chicago, today announced it has made an investment in Pinstripes, Inc. (“Pinstripes” or the “Company”), an operator of dining and entertainment venues combining bowling, bocce, and Italian-American cuisine. Pinstripes…

Read More

Revolutionizing Esophageal Treatment: Biostage Launches Clinical Trial for Severe Disease

Biostage Advances Clinical Trial for Esophageal Diseases HOLLISTON, Mass., May 31, 2023 (GLOBE NEWSWIRE) — Biostage, Inc. (OTCQB: BSTG) Introduction Biostage, a leading biotechnology company, is making significant progress in the development of groundbreaking technology aimed at regenerating organs within the body to combat various severe illnesses. The company’s focus lies in treating diseases such…

Read More

Maximizing Profitability: Healthcare Triangle to Showcase Expertise at 2023 MUSE Inspire Conference as Exhibitor and Host of Best Practice Sessions

Healthcare Triangle to Participate in 2023 MUSE Inspire Conference as Exhibit Introduction Healthcare Triangle, Inc (Nasdaq: HCTI) is gearing up to participate in the highly anticipated 2023 MUSE Inspire Conference as an exhibit. The conference, known for bringing together industry experts and thought leaders in the healthcare and life sciences sectors, offers a unique platform…

Read More

Unleashing the Power of Instagram: A Heartfelt Guide to Strategically Boosting Your Likes

The 6 Websites to Accelerate Your Instagram Strategy: Best Platforms for Buying Likes In today’s digital age Instagram has emerged as one of the most influential social media platforms for individuals and businesses alike. With over a billion monthly active users, it offers immense potential for reaching and engaging with a massive audience. However, building…

Read More

Unlocking the Potential of Caplyta: Intra-Cellular Therapies to Showcase Promising Data at the American Society of Clinical Psychopharmacology Annual Meeting

Intra-Cellular Therapies Announces CAPLYTA Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting New York, May 31, 2023 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced several CAPLYTA data presentations at the American Society…

Read More